Scilex Holding Co — Director's Dealing 2022

Nov 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Scilex Holding Company/DE (SCLX)
CIK: 0001820190
Period of Report: 2022-11-23

Reporting Person: Sorrento Therapeutics, Inc. (10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-23	Warrants to Purchase Common Stock	$11.50	P	442829	Acquired	2027-11-10	Common Stock (442829)	Direct

Footnotes

F1: The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2444 to $0.45 per warrant, inclusive. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, full information regarding the number of warrants purchased at each separate price.